Context
South Asians are more prone to develop type 2 diabetes (T2D) coinciding with earlier complications than Europids. While inflammation plays a central role in the development and progression of T2D, this factor is still underexplored in South Asians.
Objective
To study whether circulating mRNA transcripts of immune genes are different between South Asian versus Europid patients with T2D.
Design
Secondary analysis of two randomized controlled trials.
Participants
Dutch South Asian (n = 45; age: 55 ± 10 years, BMI: 29 ± 4 kg/m2) and Dutch Europid (n = 44; age: 60 ± 7 years, BMI: 32 ± 4 kg/m2) patients with T2D.
Main outcome measures
mRNA transcripts of 182 immune genes (microfluidic qPCR; Fluidigm Inc., USA) in fasted whole blood, ingenuity pathway analyses (Qiagen, USA).
Results
South Asians, compared to Europids, had higher mRNA levels of B cell markers [CD19, CD79A, CD79B, CR2, CXCR5, IGHD, MS4A1, PAX5; all FC > 1.3, FDR < 0.008] and IFN signaling genes [CD274, GBP1, GBP2, GBP5, FCGR1A/B/CP, IFI16, IFIT3, IFITM1, IFITM3, TAP1; all FC > 1.2, FDR < 0.05]. In South Asians, the IFN signaling pathway was the top canonical pathway (z-score 2.6, P < 0.001) and this was accompanied by higher plasma IFN-γ levels (FC = 1.5, FDR = 0.01). Notably, the ethnic difference in gene expression was larger for females [20/182 (11%)] than males [2/182 (1%)].
Conclusions
South Asian patients with T2D show a more activated IFN signaling pathway compared to Europid patients with T2D, which is more pronounced in females than males. We speculate that a more activated IFN signaling pathway may contribute to the more rapid progression of T2D in South Asians compared with Europids.